載入...
Development of a novel albumin-based and maleimidopropionic acid-conjugated peptide with prolonged half-life and increased in vivo anti-tumor efficacy
Angiogenesis plays a critical role in tumor aggressiveness, and a lot of anti-angiogenic agents have been used in clinical therapy. The therapeutic efficacy of peptides are generally restricted by the short in vivo life-time, thus, we were interested in developing a novel albumin-based and maleimido...
Na minha lista:
| 發表在: | Theranostics |
|---|---|
| Main Authors: | , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Ivyspring International Publisher
2018
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5928873/ https://ncbi.nlm.nih.gov/pubmed/29721065 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/thno.22069 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|